George Clinical’s emphasis on employing strict safety reporting guidelines from the design stage of a trial ensures the quality and efficiency of our services and the safety of patients who participate in our trials.
George Clinical’s safety and pharmacovigilance experts ensure that a patient’s safety is paramount. Critical to the success of any clinical trial is the early identification and management of adverse events.
George Clinical has a dedicated safety group employed at all stages of a trial to identify and coordinate the management of adverse events.
Our safety and pharmacovigilance team operate globally.
Our experienced safety and pharmacovigilance team provides:
TARA is a web-based, fully validated, ISO 9001 accredited, 21 CFR Part 11 compliant pharmacovigilance system. TARA provides all the functionality required to manage adverse event collection and reporting duties, providing an extensive list of capabilities, including but not limited to, producing necessary regulatory reporting formats for global safety submissions (including CIOMS-I, CIOMS-II, Medwatch, VAERs and E2B), dictionary input and access (including WHO, MedDRA, and PubMed), and data extracts in various formats (*.xml, *.csv, *.xls) suitable for integrations into other clinical systems. TARA is extremely versatile, facilitating faster and easier management of adverse reactions with a configurable workflow, customisable console, and straightforward end user and administrative setup. TARA can be implemented for a single clinical trial or can form the central safety management system for a clinical development program and lifecycle management.